RxDoctor Payments Data

Jordan Dau

Optometrist · Saint Johns, FLNPI 1104206325

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $46,555 of the $76,994 with a category attached, or 60.5%. Coopervision Inc. accounts for 94.7% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $29,323, more than ten times the $579 reported in 2019. Among optometrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$76,994in general payments, 2019–2025

Across 240 payments — averaging $320.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopervision Inc.$73K
  • Alcon$1K
  • Bausch & Lomb Americas Inc.$536
  • ABB Con-cise Optical Group LLC$361
  • Johnson & Johnson Vision Care, Inc.$301
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$261
  • plus $1K from 12 others
$25,325in research payments, 2019–2025

Across 6 payments — averaging $4220.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Coopervision Inc.$25K

What the payments were for

  • Consulting fees$1,2352%
  • Speaking & faculty fees$46,55560%
  • Travel & lodging$20,63427%
  • Food & beverage$8,42611%
  • Entertainment$1450%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$76,994 in reported general payments places this provider in the 95th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida

Medicare billing

Part B allowed, 2024
$2,471
Medicare patients
20
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Timolol Maleate16$96

Paid to pharmacies, not to this prescriber.

Other optometrist in Saint Johns

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →